| Net Cash Provided by (Used in) Operating Activities |
$322,080 |
USD |
-50% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$1,607,893 |
USD |
-40% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$679,370 |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
10,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
4,594,319 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0.1 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$606,443 |
USD |
48% |
Q1 2025 |
Q1 2025 |
| Payments to Acquire Property, Plant, and Equipment |
$3,608 |
USD |
-84% |
Q1 2025 |
Q1 2025 |
| Property, Plant and Equipment, Gross |
$8,185,046 |
USD |
4.5% |
Q3 2025 |
Q3 2025 |
| Deferred Income Tax Expense (Benefit) |
$38,391 |
USD |
-46% |
Q1 2025 |
Q1 2025 |
| Deferred Federal Income Tax Expense (Benefit) |
$84,099 |
USD |
-40% |
Q3 2025 |
Q3 2025 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q3 2025 |
Q3 2025 |
| Current State and Local Tax Expense (Benefit) |
$1,393 |
USD |
83% |
Q3 2025 |
Q3 2025 |
| Current Federal Tax Expense (Benefit) |
$420,470 |
USD |
-60% |
Q3 2025 |
Q3 2025 |
| Depreciation, Depletion and Amortization |
$25,030 |
USD |
5.6% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$611,599 |
USD |
26% |
Q4 2024 |
FY 2024 |